Csenge Advisory Group Novartis Ag Transaction History

Csenge Advisory Group

$1.81 Billion
Q4 2024

A detailed history of Csenge Advisory Group transactions in Novartis Ag stock. As of the latest transaction made, Csenge Advisory Group holds 16,395 shares of NVS stock, worth $1.73 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

16,395

Previous 10,026 63.52%

Holding current value

$1.73 Million

Previous $1.15 Million 38.33%

% of portfolio

0.09%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$96.78 - $117.18 $616,391 - $746,319	6,369 Added 63.52%	16,395 $1.6 Million
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $71,956 - $81,963	678 Added 7.25%	10,026 $1.15 Million
Q2 2024 Jul 10, 2024	BUY	$92.57 - $107.37 $258,455 - $299,777	2,792 Added 42.59%	9,348 $995,000
Q1 2024 May 03, 2024	SELL	$95.27 - $108.47 $130,043 - $148,061	-1,365 Reduced 17.23%	6,556 $634,000
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $74,369 - $81,841	806 Added 11.33%	7,921 $799,000
Q3 2023 Nov 01, 2023	BUY	$94.73 - $105.13 $351,353 - $389,927	3,709 Added 108.9%	7,115 $724,000
Q2 2023 Jul 20, 2023	BUY	$92.52 - $104.91 $315,123 - $357,323	3,406 New	3,406 $343,000
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $197,074 - $217,674	-2,312 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $12,608 - $14,868	-151 Reduced 6.13%	2,312 $202,000
Q4 2020 Jan 26, 2021	SELL	$78.07 - $94.43 $35,053 - $42,399	-449 Reduced 15.42%	2,463 $233,000
Q3 2020 Nov 09, 2020	BUY	$82.14 - $91.0 $3,860 - $4,277	47 Added 1.64%	2,912 $252,000
Q2 2020 Jul 17, 2020	SELL	$80.93 - $91.1 $44,673 - $50,287	-552 Reduced 16.15%	2,865 $250,000
Q1 2020 Apr 21, 2020	BUY	$70.67 - $99.01 $241,479 - $338,317	3,417 New	3,417 $282,000
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $1,546 - $1,722	-21 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$66.94 - $77.43 $1,405 - $1,626	21 New	21 $1,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Novartis Ag Transaction History